LEADER 04225nam 22006735 450 001 9910484453403321 005 20251113210928.0 010 $a3-030-51740-3 024 7 $a10.1007/978-3-030-51740-3 035 $a(CKB)4100000011645185 035 $a(DE-He213)978-3-030-51740-3 035 $a(MiAaPQ)EBC6422685 035 $a(PPN)252517237 035 $a(MiAaPQ)EBC29095893 035 $a(EXLCZ)994100000011645185 100 $a20201208d2021 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDrug Allergy $eClinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships /$fby Brian A. Baldo, Nghia H. Pham 205 $a2nd ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (XXII, 732 p. 330 illus., 162 illus. in color.) 311 08$a3-030-51739-X 320 $aIncludes bibliographical references and index. 327 $aCh. 1. Adverse reactions to drugs and drug allergy -- Ch. 2. Classification and descriptions of allergic reactions to drugs -- Ch. 3. Mechanisms of hypersensitivity -- Ch. 4. Diagnosis of allergic reactions to drugs -- Ch. 5. Beta-Lactam antibiotics -- Ch. 6. Other antimicrobial drugs -- Ch. 7. Drugs and other agents used in anesthesia and surgery -- Ch. 8. Opioid analgesic drugs -- Ch. 9. Nonsteroidal anti-inflammatory drugs -- Ch. 10. Contrast media -- Ch. 11. Corticosteroids -- Ch. 12. Proton pump inhibitors -- Ch. 13. Targeted drugs for cancer therapy. Approved monoclonal antibodies -- Ch. 14. Non-targeted drugs for cancer therapy -- Ch. 15. Other approved therapeutic monoclonal antibodies -- Ch. 16. Other biologics -- Ch. 17. Vaccines. 330 $aThe second edition of this book spans the broad range of modern therapeutic drugs, from small molecules to biologic recombinant proteins. It offers a comprehensive review of the classification and description of different drug-induced systemic and cutaneous hypersensitivities; an up-to-date coverage of individual culprit drugs in each group of therapeutics; the diagnosis and mechanisms of reactions; and important structure-activity relationships. New content expands to two areas of drug allergy that have recently experienced explosive growth: biological therapies and new targeted chemotherapies. Other new and expanded chapters address antimicrobials; drugs used in anesthesia and surgery; opioids; non-targeted anti-cancer drugs; vaccines; and newly understood reaction mechanisms. This new edition includes photographs of a wide variety of cutaneous manifestations that will be of use to other clinicians as well as allergists and dermatologists. In addition to its wide clinical emphasis, the book?s mechanistic and structure-activity detail will provide valuable background for researchers and investigators in universities, medical research institutes, drug companies, and regulatory agencies. The second edition of Drug Allergy is an essential reference for practitioners across the medical disciplines from specialist clinicians, surgeons, GPs, residents, and medical students to nurses, pharmacists, dentists, and those taking undergraduate and graduate courses in the biomedical sciences. 606 $aAllergy 606 $aRespiratory organs$xDiseases 606 $aPrimary care (Medicine) 606 $aDermatology 606 $aAnesthesiology 606 $aAllergology 606 $aPneumology 606 $aPrimary Care Medicine 606 $aDermatology 606 $aAnesthesiology 615 0$aAllergy. 615 0$aRespiratory organs$xDiseases. 615 0$aPrimary care (Medicine). 615 0$aDermatology. 615 0$aAnesthesiology. 615 14$aAllergology. 615 24$aPneumology. 615 24$aPrimary Care Medicine. 615 24$aDermatology. 615 24$aAnesthesiology. 676 $a616.9758 700 $aBaldo$b B. A.$01227802 702 $aPham$b Nghia H. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910484453403321 996 $aDrug allergy$92850761 997 $aUNINA